Atlas Energy, L.P (NYSE:ATLS) belongs to Basic Materials sector. Its net profit margin is -22.00% and weekly performance is -16.70%. On last trading day company shares ended up $3.99. Atlas Energy, L.P (NYSE:ATLS) distance from 50-day simple moving average (SMA50) is -37.09%. Wells Fargo & Co. reissued their market perform rating on shares of Atlas Energy (NYSE:ATLS) in a research report released on Thursday morning.
American Realty Capital Properties, Inc. (NASDAQ:ARCP) shares increased 1.33% in last trading session and ended the day at $8.41. ARCP Gross Margin is 91.60% and its return on assets is -3.80%. American Realty Capital Properties, Inc. (NASDAQ:ARCP) quarterly performance is -13.57%. The Board of Directors of American Realty Capital Properties, Inc. (NASDAQ: ARCP) has scheduled the Company’s 2015 Annual Meeting of Stockholders (the “Annual Meeting”) for Tuesday, September 29, 2015.
On 10 July, Biglari Holdings Inc. (NYSE:BH) shares decreased -0.31% and was closed at $427.78. BH EPS growth in last 5 year was 77.60%. Biglari Holdings Inc. (NYSE:BH) year to date (YTD) performance is 7.08%. The Lion Fund II, L.P. announced the preliminary results of its tender offer to purchase for cash up to 575,000 shares of the common stock of Biglari Holdings Inc. (NYSE:BH) at a purchase price of $420.00 per share. The tender offer expired at 11:59 p.m., New York City Time, on July 1, 2015.
Loews Corporation (NYSE:L) ended the last trading day at $38.83. Company weekly volatility is calculated as 1.46% and price to cash ratio as 53.21. Loews Corporation (NYSE:L) showed a weekly performance of 0.36%. Loews Corporation (NYSE: L) will report second quarter 2015 financial results on Monday, August 3, 2015. A conference call for analysts and investors will begin at 11:00 a.m. EDT and will be hosted by the Company’s chief executive officer, James S. Tisch, and chief financial officer, David B. Edelson.
Intersect ENT, Inc. (NASDAQ:XENT) shares advanced 3.77% in last trading session and ended the day at $29.48. XENT Gross Margin is 76.00% and its return on assets is -38.70%. Intersect ENT, Inc. (NASDAQ:XENT) quarterly performance is 10.95%. Intersect ENT, Inc. (NASDAQ:XENT) announced the enrollment of the first patient in the company’s pivotal study of its latest bioabsorbable steroid releasing sinus implant, currently called NOVA. NOVA is designed to mechanically prop sinuses open while delivering anti-inflammatory medication following surgical interventions such as sinus surgery in the operating room or in-office sinus dilation.